Found 19 matching trials
A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI PHASE3 This study is a multicenter, open-label, randomized controlled trial that e...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
CM082 in Patients With Myopic Choroidal Neovascularization (CNV) PHASE1 This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinet...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors PHASE1 This is a two-agent, open-label, non-randomized, Phase 1/2 dose escalation ...
Show More Location
Stanford Cancer Institute
Learn More & Join Trial
Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study PHASE2 This study evaluates the efficacy and safety of Vorolanib as monotherapy fo...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma. PHASE2 This study was a one-arm, single-center, phase II clinical study. Patients ...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients PHASE1 Evaluate the efficacy and safety of vorolanib combined with cadonilimab in ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors PHASE1 This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinet...
Show More Location
Shanghai East Hospital
Learn More & Join Trial
Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer PHASE1 This is an open-label, Phase 1b study which will be conducted in two parts:...
Show More Location
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Learn More & Join Trial
A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer PHASE2 Small cell lung cancer (SCLC) accounts for 15% of lung cancer cases and is ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers PHASE1 The main objective of this study is to evaluate the Effect of Food on the P...
Show More Location
The 1st Phase Clinical Research Center of the Second Affiliated Hospital of Zhejiang University Medical College
Learn More & Join Trial